{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:40:05Z","timestamp":1793259605394,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["81801901"],"award-info":[{"award-number":["81801901"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["81801901"],"award-info":[{"award-number":["81801901"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-115"],"award-info":[{"award-number":["2022-PUMCH-B-115"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-024-00806-x","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:07:31Z","timestamp":1736165251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of different antiplatelet therapy drugs on platelet activation and platelet-leukocyte aggregate formation in early septic ARDS"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6553-6381","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-yu","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-3109","authenticated-orcid":false,"given":"Huai-Wu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0274-8322","authenticated-orcid":false,"given":"Yun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"issue":"8","key":"806_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"806_CR2","doi-asserted-by":"publisher","unstructured":"Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc. 2012;60(6):1070\u20137. https:\/\/doi.org\/10.1111\/j.1532-5415.2012.03989.x.","DOI":"10.1111\/j.1532-5415.2012.03989.x"},{"key":"806_CR3","doi-asserted-by":"publisher","unstructured":"Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med. 1997;23(4):379\u2013\u200985. https:\/\/doi.org\/10.1007\/s001340050344.","DOI":"10.1007\/s001340050344"},{"issue":"3","key":"806_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/SHK.0000000000001518","volume":"54","author":"Z Chen","year":"2020","unstructured":"Chen Z, Liu C, Jiang Y, Liu H, Shao L, Zhang K, Cheng D, Zhou Y, Chong W. HDAC inhibitor attenuated NETs formation induced by activated platelets in Vitro, partially through downregulating platelet secretion. Shock. 2020;54(3):321\u20139. https:\/\/doi.org\/10.1097\/SHK.0000000000001518.","journal-title":"Shock"},{"key":"806_CR5","doi-asserted-by":"publisher","unstructured":"A feedback loop between platelets and NETs amplifies inflammation in severe sepsis. Nat Cardiovasc Res. 2022;1(8):698\u20139. https:\/\/doi.org\/10.1038\/s44161-022-00110-z.","DOI":"10.1038\/s44161-022-00110-z"},{"key":"806_CR6","doi-asserted-by":"publisher","unstructured":"Washington AV, Esponda O, Gibson A. Platelet biology of the rapidly failing lung. Br J Haematol. 2020;188(5):641\u201351. https:\/\/doi.org\/10.1111\/bjh.16315.","DOI":"10.1111\/bjh.16315"},{"issue":"3","key":"806_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1182\/bloodadvances.2018026286","volume":"3","author":"W Bain","year":"2019","unstructured":"Bain W, Olonisakin T, Yu M, Qu Y, Hulver M, Xiong Z, Li H, Pilewski J, Mallampalli RK, Nouraie M, et al. Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury. Blood Adv. 2019;3(3):432\u201345. https:\/\/doi.org\/10.1182\/bloodadvances.2018026286.","journal-title":"Blood Adv"},{"key":"806_CR8","doi-asserted-by":"publisher","unstructured":"Wu L, Cheng Y, Peng S, Zhang W, Zhang C. Sphingosine kinase 1 plays an important role in atorvastatin-mediated anti-inflammatory effect against acute lung injury. Mediators Inflamm. 2021;2021:9247285. https:\/\/doi.org\/10.1155\/2021\/9247285.","DOI":"10.1155\/2021\/9247285"},{"key":"806_CR9","doi-asserted-by":"publisher","unstructured":"Franco-Pelaez JA, Esteban-Lucia L, Zambrano Chacon MLA, Pello-Lazaro AM, Venegas Rodriguez AM, Nieto Roca L, Garcia-Talavera CS, Kallmeyer Mayor A, Villar Alvarez F, Fernandez Roblas R, et al. Statin use is associated with reduced mortality after respiratory viral infection. ERJ Open Res. 2021;7(1). https:\/\/doi.org\/10.1183\/23120541.00365-2020.","DOI":"10.1183\/23120541.00365-2020"},{"key":"806_CR10","doi-asserted-by":"publisher","unstructured":"Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O\u2019Kane CM, McAuley DF, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6(9):691\u20138. https:\/\/doi.org\/10.1016\/S2213-2600(18)30177-2.","DOI":"10.1016\/S2213-2600(18)30177-2"},{"issue":"5","key":"806_CR11","first-page":"227","volume":"5","author":"N Teoh","year":"2020","unstructured":"Teoh N, Farrell G. Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence. J Clin Transl Res. 2020;5(5):227\u20139.","journal-title":"J Clin Transl Res"},{"key":"806_CR12","doi-asserted-by":"publisher","unstructured":"Gelbenegger G, Jilma B. Clinical pharmacology of antiplatelet drugs. Expert Rev Clin Pharmacol. 2022;15(10):1177\u201397. https:\/\/doi.org\/10.1080\/17512433.2022.2121702.","DOI":"10.1080\/17512433.2022.2121702"},{"issue":"1","key":"806_CR13","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.1038\/s41598-023-48812-z","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang M, Liu C, Hao M, Wang W, Li Y, Shi J, Zhang X, Dang S. Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression. Sci Rep. 2023;13(1):21362. https:\/\/doi.org\/10.1038\/s41598-023-48812-z.","journal-title":"Sci Rep"},{"key":"806_CR14","doi-asserted-by":"publisher","unstructured":"Dong S, Liu Q, Zhou X, Zhao Y, Yang K, Li L, Zhu D. Effects of losartan, atorvastatin, and aspirin on blood pressure and gut microbiota in spontaneously hypertensive rats. Molecules. 2023;28(2). https:\/\/doi.org\/10.3390\/molecules28020612.","DOI":"10.3390\/molecules28020612"},{"key":"806_CR15","doi-asserted-by":"publisher","unstructured":"Mohammad HMF, Makary S, Atef H, El-Sherbiny M, Atteia HH, Ibrahim GA, Mohamed AS, Zaitone SA. Clopidogrel or prasugrel reduces mortality and lessens cardiovascular damage from acute myocardial infarction in hypercholesterolemic male rats. Life Sci. 2020;247:117429. https:\/\/doi.org\/10.1016\/j.lfs.2020.117429.","DOI":"10.1016\/j.lfs.2020.117429"},{"key":"806_CR16","doi-asserted-by":"publisher","unstructured":"Liu X, Tao GZ. Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction. J Geriatr Cardiol. 2013;10(1):52\u20138. https:\/\/doi.org\/10.3969\/j.issn.1671-5411.2013.01.009.","DOI":"10.3969\/j.issn.1671-5411.2013.01.009"},{"issue":"8","key":"806_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1080\/09537104.2022.2107627","volume":"33","author":"B Williams","year":"2022","unstructured":"Williams B, Zhu J, Zou L, Chao W. Innate immune TLR7 signaling mediates platelet activation and platelet-leukocyte aggregate formation in murine bacterial sepsis. Platelets. 2022;33(8):1251\u20139. https:\/\/doi.org\/10.1080\/09537104.2022.2107627.","journal-title":"Platelets"},{"key":"806_CR18","doi-asserted-by":"publisher","unstructured":"Schrottmaier WC, Kral-Pointner JB, Salzmann M, Mussbacher M, Schmuckenschlager A, Pirabe A, Brunnthaler L, Kuttke M, Maier B, Heber S, et al. Platelet p110beta mediates platelet-leukocyte interaction and curtails bacterial dissemination in pneumococcal pneumonia. Cell Rep. 2022;41(6):111614. https:\/\/doi.org\/10.1016\/j.celrep.2022.111614.","DOI":"10.1016\/j.celrep.2022.111614"},{"issue":"1","key":"806_CR19","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/0886022X.2021.1948864","volume":"43","author":"S Yang","year":"2021","unstructured":"Yang S, Huang X, Liao J, Li Q, Chen S, Liu C, Ling L, Zhou J. Platelet-leukocyte aggregates - a predictor for acute kidney injury after cardiac surgery. Ren Fail. 2021;43(1):1155\u201362. https:\/\/doi.org\/10.1080\/0886022X.2021.1948864.","journal-title":"Ren Fail"},{"key":"806_CR20","doi-asserted-by":"publisher","unstructured":"Chen CM, Lu HC, Tung YT, Chen W. Antiplatelet therapy for acute respiratory distress syndrome. Biomedicines. 2020;8(7). https:\/\/doi.org\/10.3390\/biomedicines8070230.","DOI":"10.3390\/biomedicines8070230"},{"key":"806_CR21","doi-asserted-by":"publisher","unstructured":"Panka BA, de Grooth HJ, Spoelstra-de Man AM, Looney MR, Tuinman PR. Prevention or treatment of ards with aspirin: a review of preclinical models and meta-analysis of clinical studies. Shock. 2017;47(1):13\u201321. https:\/\/doi.org\/10.1097\/SHK.0000000000000745.","DOI":"10.1097\/SHK.0000000000000745"},{"key":"806_CR22","doi-asserted-by":"publisher","unstructured":"Kral-Pointner JB, Schrottmaier WC, Salzmann M, Mussbacher M, Schmidt GJ, Moser B, Heber S, Birnecker B, Paar H, Zellner M, et al. Platelet PI3K modulates innate leukocyte extravasation during acid-induced acute lung inflammation. Thromb Haemost. 2019;119(10):1642\u201354. https:\/\/doi.org\/10.1055\/s-0039-1693693.","DOI":"10.1055\/s-0039-1693693"},{"key":"806_CR23","doi-asserted-by":"publisher","unstructured":"Wang XL, Deng HF, Tan CY, Xiao ZH, Liu MD, Liu K, Zhang HL, Xiao XZ. The role of PSGL-1 in pathogenesis of systemic inflammatory response and coagulopathy in endotoxemic mice. Thromb Res. 2019;182:56\u201363. https:\/\/doi.org\/10.1016\/j.thromres.2019.08.019.","DOI":"10.1016\/j.thromres.2019.08.019"},{"key":"806_CR24","doi-asserted-by":"publisher","unstructured":"Kwack WG, Lee YJ, Eo EY, Chung JH, Lee JH, Cho YJ. Simultaneous pretreatment of aspirin and omega-3 fatty acid attenuates nuclear factor-kappaB activation in a murine model with ventilator-induced lung injury. Nutrients. 2021;13(7). https:\/\/doi.org\/10.3390\/nu13072258.","DOI":"10.3390\/nu13072258"},{"key":"806_CR25","doi-asserted-by":"publisher","unstructured":"Chen CM, Tung YT, Wei CH, Lee PY, Chen W. Anti-inflammatory and reactive oxygen species suppression through aspirin pretreatment to treat hyperoxia-induced acute lung injury in NF-kappaB-luciferase inducible transgenic mice. Antioxidants (Basel). 2020;9(5). https:\/\/doi.org\/10.3390\/antiox9050429.","DOI":"10.3390\/antiox9050429"},{"key":"806_CR26","doi-asserted-by":"publisher","unstructured":"Liang H, Ding X, Li H, Li L, Sun T. Association between prior aspirin use and acute respiratory distress syndrome incidence in at-risk patients: a systematic review and meta-analysis. Front Pharmacol. 2020;11(738). https:\/\/doi.org\/10.3389\/fphar.2020.00738.","DOI":"10.3389\/fphar.2020.00738"},{"key":"806_CR27","doi-asserted-by":"publisher","unstructured":"Hamid U, Krasnodembskaya A, Fitzgerald M, Shyamsundar M, Kissenpfennig A, Scott C, Lefrancais E, Looney MR, Verghis R, Scott J, et al. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. Thorax. 2017;72(11):971\u201380. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-208571.","DOI":"10.1136\/thoraxjnl-2016-208571"},{"key":"806_CR28","doi-asserted-by":"publisher","unstructured":"Tung YT, Wei CH, Yen CC, Lee PY, Ware LB, Huang HE, Chen W, Chen CM. Aspirin attenuates hyperoxia-induced acute respiratory distress syndrome (ARDS) by suppressing pulmonary inflammation via the NF-kappaB signaling pathway. Front Pharmacol. 2021;12:793107. https:\/\/doi.org\/10.3389\/fphar.2021.793107.","DOI":"10.3389\/fphar.2021.793107"},{"key":"806_CR29","doi-asserted-by":"publisher","unstructured":"Mueen RM, Hadi NR. Lung protective effects of clopidogrel in polymicrobial sepsis. Pol Merkur Lekarski. 2023;51(4):321\u20139. https:\/\/doi.org\/10.36740\/Merkur202304104.","DOI":"10.36740\/Merkur202304104"},{"key":"806_CR30","doi-asserted-by":"publisher","unstructured":"Yu Y, Yang D, Wang Q, Li J. Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: a cohort study. Pulm Pharmacol Ther. 2024;85:102288. https:\/\/doi.org\/10.1016\/j.pupt.2024.102288.","DOI":"10.1016\/j.pupt.2024.102288"},{"key":"806_CR31","doi-asserted-by":"publisher","unstructured":"Boyle AJ, Di Gangi S, Hamid UI, Mottram LJ, McNamee L, White G, Cross LJ, McNamee JJ, O\u2019Kane CM, McAuley DF. Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis. Crit Care. 2015;19(1):109. https:\/\/doi.org\/10.1186\/s13054-015-0846-4.","DOI":"10.1186\/s13054-015-0846-4"},{"key":"806_CR32","doi-asserted-by":"publisher","unstructured":"Tuinman PR, Muller MC, Jongsma G, Hegeman MA, Juffermans NP. High-dose acetylsalicylic acid is superior to low-dose as well as to clopidogrel in preventing lipopolysaccharide-induced lung injury in mice. Shock. 2013;40(4):334\u20138. https:\/\/doi.org\/10.1097\/SHK.0b013e3182a384f0.","DOI":"10.1097\/SHK.0b013e3182a384f0"},{"key":"806_CR33","doi-asserted-by":"publisher","unstructured":"Yuan X, Jiang P, Qiao C, Su N, Sun P, Lin F, Li C. Platelet suppression by tirofiban ameliorates pulmonary coagulation and fibrinolysis abnormalities in the lungs of mouse antibody-mediated transfusion-related acute lung injury. Shock. 2023;59(4):603\u201311. https:\/\/doi.org\/10.1097\/SHK.0000000000002080.","DOI":"10.1097\/SHK.0000000000002080"},{"key":"806_CR34","doi-asserted-by":"publisher","unstructured":"McKenzie ME, Malinin AI, Bell CR, Dzhanashvili A, Horowitz ED, Oshrine BR, Atar D, Serebruany VL. Aspirin inhibits surface glycoprotein IIb\/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets. Blood Coagul Fibrinolysis. 2003;14(3):249\u201353. https:\/\/doi.org\/10.1097\/01.mbc.0000046182.72384.ab.","DOI":"10.1097\/01.mbc.0000046182.72384.ab"},{"key":"806_CR35","doi-asserted-by":"publisher","unstructured":"Le Guyader A, Pacheco G, Seaver N, Davis-Gorman G, Copeland J, McDonagh PF. Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia. J Diabetes Complications. 2009;23(1):65\u201370. https:\/\/doi.org\/10.1016\/j.jdiacomp.2007.06.003.","DOI":"10.1016\/j.jdiacomp.2007.06.003"},{"key":"806_CR36","doi-asserted-by":"publisher","unstructured":"Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther. 2003;73(3):232\u201341. https:\/\/doi.org\/10.1067\/mcp.2003.13.","DOI":"10.1067\/mcp.2003.13"},{"issue":"3","key":"806_CR37","first-page":"488","volume":"88","author":"RF Storey","year":"2002","unstructured":"Storey RF, Judge HM, Wilcox RG, Heptinstall S. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thromb Haemost. 2002;88(3):488\u201394.","journal-title":"Thromb Haemost"},{"key":"806_CR38","doi-asserted-by":"publisher","unstructured":"Klinkhardt U, Graff J, Harder S. Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model. Clin Pharmacol Ther. 2002;71(3):176\u201385. https:\/\/doi.org\/10.1067\/mcp.2002.122018.","DOI":"10.1067\/mcp.2002.122018"},{"key":"806_CR39","doi-asserted-by":"publisher","unstructured":"Giordano A, D\u2019Angelillo A, Romano S, D\u2019Arrigo P, Corcione N, Bisogni R, Messina S, Polimeno M, Pepino P, Ferraro P, et al. Tirofiban induces VEGF production and stimulates migration and proliferation of endothelial cells. Vascul Pharmacol. 2014;61(2\u20133):63\u201371. https:\/\/doi.org\/10.1016\/j.vph.2014.04.002.","DOI":"10.1016\/j.vph.2014.04.002"},{"key":"806_CR40","doi-asserted-by":"publisher","unstructured":"Giordano A, Romano S, D\u2019Angelillo A, Corcione N, Messina S, Avellino R, Biondi-Zoccai G, Ferraro P, Romano MF. Tirofiban counteracts endothelial cell apoptosis through the VEGF\/VEGFR2\/pAkt axis. Vascul Pharmacol. 2016;80:67\u201374. https:\/\/doi.org\/10.1016\/j.vph.2015.12.001.","DOI":"10.1016\/j.vph.2015.12.001"},{"key":"806_CR41","doi-asserted-by":"publisher","unstructured":"van der Poll T, Parker RI. Platelet activation and endothelial cell dysfunction. Crit Care Clin. 2020;36(2):233\u201353. https:\/\/doi.org\/10.1016\/j.ccc.2019.11.002.","DOI":"10.1016\/j.ccc.2019.11.002"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00806-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-024-00806-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00806-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T13:07:26Z","timestamp":1736168846000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-024-00806-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1186\/s40360-024-00806-x","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee (IACUC) at Peking Union Medical College, Beijing, China. (IACUC protocol number: XHDW-2023-029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have agreed to publish it.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}